Objectives: The current report describes the feasibility of robotic retroperitoneal lymph node dissection (RRPLND), including some technical tricks for port placement for both right- and left-sided surgery. Methods: Patients with advanced stage retroperitoneal disease underwent RRPLND using the 4-arm da Vinci Si Surgical System (Intuitive Surgical, Inc.). In both cases, the field of dissection was an ipsilateral template for lymph node dissection. Results: RRPLND in such configuration was safe and effective in both cases. The illustrated port placement with perpendicular docking of the robot allowed for a wide range of motion with limited external clashing, providing sufficient space for the assistant surgeon. The operative time was 300 min (including docking and console time), with no perioperative complications and short hospital stay. Conclusion: The port configuration for right- or left-sided unilateral template RRPLND was feasible, permitting a wide range of motion for the robotic arms and thus facilitating an efficient and safe dissection.

Keywords:
Robotic surgery, Modified left template, Retroperitoneal lymph node dissection, Modified right template
1.
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, Nicolai N, Oldenburg J: Guidelines on testicular cancer: 2015 update. Eur Urol 2015;68:1054-1068.
2.
Rassweiler JJ, Scheitlin W, Heidenreich A, Laguna MP, Janetschek G: Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol 2008;54:1004-1015.
3.
Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L: Contemporary management of postchemotherapy testis cancer. Eur Urol 2012;62:867-876.
4.
Chalfin HJ, Ludwig W, Pierorazio PM, Allaf ME: Robotic primary RPLND for stage I testicular cancer: a review of indications and outcomes. Curr Urol Rep 2016;17:41.
5.
Davol P, Sumfest J, Rukstalis D: Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 2006;67:199.
6.
de Cobelli O, Brescia A, Mazzoleni F, Musi G, Matei DV: A novel ‘intuitive' surgical technique for right robot-assisted retroperitoneal lymph node dissection for stage I testicular NSGCT. World J Urol 2013;31:435-439.
7.
Dogra PN, Singh P, Saini AK, Regmi KS, Singh BG, Nayak B: Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor. Urol Ann 2013;5:223-236.
8.
Mir MC, Autorino R, Samarasekera D, Klink J, Stephenson AJ, Kaouk JH: Robot-assisted laparoscopic retroperitoneal lymph node dissection for left clinical stage I non-seminomatous germ cell testicular cancer: focus on port placement and surgical technique. Int J Urol 2014;21:212-214.
9.
Cheney SM, Andrews PE, Leibovich BC, Castle EP: Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. BJU Int 2015;115:114-120.
10.
Abdul-Muhsin HM, L'esperance JO, Fischer K, Woods ME, Porter JR, Castle EP: Robot-assisted retroperitoneal lymph node dissection in testicular cancer. J Surg Oncol 2015;112:736-740.
11.
Stepanian S, Patel M, Porter J: Robot-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer: evolution of the technique. Eur Urol 2016;pii:S0302-2838(16)00385-7.
12.
Lee SH, Kim DS, Chang SG, Jeon SH: Robot-assisted laparoscopic retroperitoneal lymph node dissection for stage IIIb mixed germ cell testicular cancer after chemotherapy. Korean J Urol 2015;56:540-544.
13.
Kamel MH, Littlejohn N, Cox M, Eltahawy EA, Davis R: Post-chemotherapy robotic retroperitoneal lymph node dissection: institutional experience. J Endourol 2016;30:510-519.
14.
Sharma P, Sverrisson EF, Zargar-Shoshtari K, Fishman MN, Sexton WJ, Dickinson SI, Spiess PE, Poch MA, Gilbert SM, Pow-Sang JM: Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma. Can J Urol 2015;22:7882-7889.
15.
Heidenreich A, Pfister D, Witthuhn R, Thüer D, Albers P: Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol 2009;55:217-224.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.